US M&A and equity raisings
3,392 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds
Deals dated after 30 September 2026 are still being collected.
445 deals · US$333bndisclosed · Healthcare · Clear
Columns
| Date | Target | Vendor | Acquirer | Type | Status | Value US$m | Sector | Advisers |
|---|---|---|---|---|---|---|---|---|
| Mar 2026 | Day One Biopharmaceuticals | – | Servier | Acquisition | Pending | 2,500.0 | Biotech+2 | Centerview Partners (sell-side)Fenwick & West (sell-side)Goldman Sachs (buy-side)Baker McKenzie (buy-side)Innisfree M&A (buy-side) |
| Mar 2026 | Four Community Health Systems Arkansas hospitals and outpatient operations | Community Health Systems | Freeman Health System | Asset sale | Completed | 110.0 | Healthcare Services | Leerink Partners (sell-side) |
| Mar 2026 | Data Dimensions | Thompson Street Capital Partners | One Call | Acquisition | Announced | – | Business Services+2 | Baird (sell-side)Davis Polk (buy-side)Moelis & Company (buy-side) |
| Mar 2026 | Preferred Vascular Group | – | Surgery Partners | Acquisition | Announced | – | Healthcare Services | Ziegler (sell-side)Benesch Friedlander Coplan & Aronoff (sell-side)McDermott Will & Schulte (buy-side) |
| Mar 2026 | Corstasis Therapeutics | – | Esperion Therapeutics | Acquisition | Completed | 75.0 | Pharma+1 | PJT Partners (sell-side)Arnold & Porter (sell-side)Jefferies (buy-side)Gibson Dunn (buy-side) |
| Mar 2026 | Unleash-owned rights to UIO-524, UIO-525 and UIO-526 | Unleash Immuno Oncolytics | TransCode Therapeutics | Asset sale | Pending | – | Biotech+2 | Tungsten Advisors |
| Mar 2026 | Select Medical Holdings | – | Consortium led by Robert A. Ortenzio, Martin F. Jackson and WCAS | Acquisition | Completed | 3,900.0 | Healthcare Services | Goldman Sachs (sell-side)Skadden, Arps, Slate, Meagher & Flom (sell-side)Dechert (sell-side)Wells Fargo Securities (buy-side)J.P. Morgan (buy-side)Cravath, Swaine & Moore (buy-side)Barclays (buy-side)Ropes & Gray (buy-side) |
| Mar 2026 | Cullgen | – | Gyre Therapeutics | Acquisition | Pending | 300.0 | Biotech+1 | Mintz (sell-side)Moelis & Company (buy-side)Gibson Dunn (buy-side) |
| Mar 2026 | Candid Therapeutics | – | Rallybio | Acquisition | Pending | – | Biotech+1 | Wedbush Securities (sell-side)Cooley (sell-side)Evercore (buy-side)Citizens JMP (buy-side)Ropes & Gray (buy-side) |
| Mar 2026 | Advanced Care Partners | Council Capital | Angels of Care | Acquisition | Completed | – | Healthcare Services | Edgemont Partners (sell-side) |
| Mar 2026 | Moxe Health | – | BV Investment Partners | Acquisition | Announced | – | Healthcare Software | Piper Sandler (sell-side) |
| Mar 2026 | Arrive Health | – | – | Merger | Completed | – | Healthcare Software+1 | Kirkland & EllisTripleTreePiper Sandler (sell-side) |
| Mar 2026 | Lonza Capsules & Health Ingredients division | Lonza Group AG | Lone Star Funds | Asset sale | Announced | – | Pharmaceutical Manufacturing+2 | Kirkland & Ellis (buy-side) |
| Mar 2026 | Scientia Vascular | – | Medtronic | Acquisition | Announced | 550.0 | Medtech+1 | Latham & Watkins (sell-side) |
| Mar 2026 | Transcend Therapeutics | – | Otsuka | Acquisition | Announced | 700.0 | Biotech+2 | Kirkland & Ellis (sell-side)Goodwin (sell-side)Centerview Partners (sell-side)Skadden, Arps, Slate, Meagher & Flom (buy-side) |
| Mar 2026 | Crossover Health | – | – | Merger | Completed | – | Healthcare Services | Latham & Watkins |
| Mar 2026 | DentaNet | Southland Benefit Solutions | Principal Financial Group | Asset sale | Announced | – | Insurance+1 | Skadden, Arps, Slate, Meagher & Flom (buy-side) |
| Mar 2026 | CirrusMD | – | Quantum Health | Acquisition | Announced | – | Healthcare Services+1 | Lincoln International (sell-side)Kirkland & Ellis (buy-side) |
| Mar 2026 | Paratek Pharmaceuticals | – | – | Merger | Completed | – | Pharma | Skadden, Arps, Slate, Meagher & Flom |
| Mar 2026 | Manufacturing facility in Phoenix, AZ | Bristol Myers Squibb | Rovi | Asset sale | Completed | – | Pharmaceutical Manufacturing+1 | William Blair |
| Mar 2026 | Global Healthcare Exchange | Temasek | Veritas Capital | Acquisition | Completed | – | Healthcare Software | Baird (buy-side) |
| Mar 2026 | Integra Partners | – | Windrose Health Investors | Acquisition | Completed | – | Healthcare Services+1 | TripleTree |
| Feb 2026 | AiCuris Anti-infective Cures AG | – | Veloxis Pharmaceuticals | Acquisition | Announced | 913.0 | Pharma+1 | Gibson Dunn (sell-side)Freshfields (buy-side) |
| Feb 2026 | Consilium360 | – | Zemantics Ventures | Acquisition | Completed | – | Healthcare Services+1 | Hunt Scanlon Ventures (buy-side) |
| Feb 2026 | MedWell360 | – | Zemantics Ventures | Acquisition | Completed | – | Healthcare Services+1 | Hunt Scanlon Ventures (buy-side) |
| Feb 2026 | Arcellx | – | Gilead Sciences | Acquisition | Announced | 7,800.0 | Biotech+2 | Centerview Partners (sell-side)Wilson Sonsini Goodrich & Rosati (sell-side)BofA Securities (buy-side)Morgan Stanley (buy-side)Ropes & Gray (buy-side)Innisfree M&A (buy-side) |
| Feb 2026 | Enhabit | – | Kinderhook Industries | Acquisition | Completed | 1,100.0 | Healthcare Services | Goldman Sachs (sell-side)Jones Day (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Guggenheim Securities (buy-side)Kirkland & Ellis (buy-side) |
| Feb 2026 | TrustCommerce | – | RevSpring | Acquisition | Completed | – | Payments+1 | William BlairFinancial Technology Partners (sell-side) |
| Feb 2026 | Uromedica | – | Coloplast A/S | Acquisition | Announced | – | Medtech | Davis Polk (buy-side) |
| Feb 2026 | MWI Animal Health | Cencora | Covetrus | Merger | Pending | 3,500.0 | Animal Health+2 | Guggenheim Securities (sell-side)Morgan Stanley (sell-side)Freshfields (sell-side)Goldman Sachs (buy-side)Wells Fargo Securities (buy-side)Deutsche Bank (buy-side)Rabobank (buy-side)Greenhill (buy-side)Natixis (buy-side)Societe Generale (buy-side)TD Securities (buy-side)ING (buy-side)Standard Chartered (buy-side)Debevoise & Plimpton (buy-side)Latham & Watkins (buy-side) |
| Feb 2026 | Medfluencers | – | HealthCentral | Acquisition | Completed | – | Advertising and marketing+2 | Morgan Lewis (sell-side)Edgemont Partners (sell-side) |
| Feb 2026 | Faeth Therapeutics | – | Sensei Biotherapeutics | Acquisition | Completed | – | Biotech+2 | Cooley (sell-side)Lucid Capital Markets (buy-side)Sidley Austin (buy-side) |
| Feb 2026 | MaxHealth | Arsenal Capital Partners | CenterWell | Acquisition | Completed | – | Healthcare Services | Sidley Austin (sell-side)Guggenheim Securities (sell-side)Morgan Stanley (sell-side)Latham & Watkins (buy-side)J.P. Morgan (buy-side) |
| Feb 2026 | Masimo | – | Danaher | Acquisition | Announced | 9,900.0 | Medtech+1 | McDermott Will & SchulteCenterview Partners (sell-side)Morgan Stanley (sell-side)Sullivan & Cromwell (sell-side)White & Case (sell-side)Longacre Square Partners (sell-side)Citi (buy-side)Kirkland & Ellis (buy-side) |
| Feb 2026 | Bruder Consulting & Venture Group | – | Dark Horse Consulting Group | Acquisition | Completed | – | Accounting, legal and consulting+1 | Goodwin (sell-side)Edgemont Partners (sell-side) |
| Feb 2026 | Laysan Bio | – | Gannet BioChem | Acquisition | Announced | – | Pharma Services+2 | Goodwin (buy-side) |
| Feb 2026 | Paradigm | – | Patient Square Capital | Acquisition | Announced | – | Healthcare Services | Weil, Gotshal & Manges (sell-side) |
| Feb 2026 | Avadel Pharmaceuticals | – | Alkermes | Scheme | Completed | – | Pharma+1 | Goldman Sachs (sell-side)Morgan Stanley (sell-side)J.P. Morgan (buy-side) |
| Feb 2026 | Broth | – | Supreme Group | Acquisition | Announced | – | Advertising and marketing+1 | Edgemont Partners (sell-side) |
| Feb 2026 | Orna Therapeutics | – | Eli Lilly and Company | Acquisition | Announced | 2,400.0 | Biotech+1 | Lazard (sell-side)Goodwin (sell-side)Paul, Weiss (buy-side) |
| Feb 2026 | LearnWell | – | Goldman Sachs Alternatives (Sustainable Investing) | Acquisition | Completed | – | Education+1 | Harris Williams (sell-side)Latham & Watkins (buy-side) |
| Feb 2026 | Apploi | – | Viventium | Acquisition | Completed | – | HR Software+2 | Houlihan Lokey (sell-side)Dentons Canada (sell-side)Goodwin (buy-side) |
| Feb 2026 | Dutscher Group | – | Vivo Capital | Acquisition | Announced | – | Life Sciences+1 | Sidley Austin (buy-side)Mayer Brown (buy-side) |
| Feb 2026 | LKC Technologies | DW Healthcare Partners | AMETEK | Acquisition | Announced | – | Medtech+2 | William Blair (sell-side) |
| Feb 2026 | Elara Caring | – | Ares Management | Stake | Announced | – | Healthcare Services+1 | Debevoise & Plimpton (sell-side)Evercore (sell-side)Guggenheim Securities (buy-side) |
| Feb 2026 | PrimeGen US | – | DT Cloud Star Acquisition | Merger | Announced | 1,500.0 | Biotech+1 | A.G.P./Alliance Global Partners (sell-side)Sichenzia Ross Ference Carmel (sell-side)Loeb & Loeb (buy-side) |
| Feb 2026 | Wilmington Dermatology Center | – | DermCare Management | Acquisition | Completed | – | Dermatology+2 | Capstone Partners (sell-side) |
| Feb 2026 | Compass Health Brands | – | Drive Medical | Acquisition | Announced | – | Consumer Health+2 | Capstone Partners (sell-side) |
| Feb 2026 | KabaFusion | Novo Holdings | Nautic Partners | Stake | Announced | – | Healthcare Services | Kirkland & Ellis (buy-side) |
| Feb 2026 | JusticeWorks YouthCare | – | Omni Family of Services | Acquisition | Completed | – | Behavioral Health | Capstone Partners (sell-side) |
Deals come from SEC filings (merger proxies, tender offers, 8-K announcements and IPO prospectuses), the deal pages and transaction lists of law firms and banks, companies' press releases and the press. How the data is built